1. Home
  2. OPK vs ECPG Comparison

OPK vs ECPG Comparison

Compare OPK & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • ECPG
  • Stock Information
  • Founded
  • OPK 2007
  • ECPG 1998
  • Country
  • OPK United States
  • ECPG United States
  • Employees
  • OPK N/A
  • ECPG N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • ECPG Finance Companies
  • Sector
  • OPK Health Care
  • ECPG Finance
  • Exchange
  • OPK Nasdaq
  • ECPG Nasdaq
  • Market Cap
  • OPK 1.1B
  • ECPG 806.1M
  • IPO Year
  • OPK 1995
  • ECPG 1999
  • Fundamental
  • Price
  • OPK $1.35
  • ECPG $38.15
  • Analyst Decision
  • OPK Buy
  • ECPG Strong Buy
  • Analyst Count
  • OPK 4
  • ECPG 3
  • Target Price
  • OPK $2.75
  • ECPG $62.67
  • AVG Volume (30 Days)
  • OPK 3.1M
  • ECPG 262.2K
  • Earning Date
  • OPK 08-06-2025
  • ECPG 08-06-2025
  • Dividend Yield
  • OPK N/A
  • ECPG N/A
  • EPS Growth
  • OPK N/A
  • ECPG N/A
  • EPS
  • OPK N/A
  • ECPG N/A
  • Revenue
  • OPK $689,408,000.00
  • ECPG $1,380,750,000.00
  • Revenue This Year
  • OPK N/A
  • ECPG $21.70
  • Revenue Next Year
  • OPK $6.98
  • ECPG $8.86
  • P/E Ratio
  • OPK N/A
  • ECPG N/A
  • Revenue Growth
  • OPK N/A
  • ECPG 11.49
  • 52 Week Low
  • OPK $1.21
  • ECPG $26.45
  • 52 Week High
  • OPK $2.04
  • ECPG $51.77
  • Technical
  • Relative Strength Index (RSI)
  • OPK 59.19
  • ECPG 50.74
  • Support Level
  • OPK $1.33
  • ECPG $37.52
  • Resistance Level
  • OPK $1.42
  • ECPG $41.56
  • Average True Range (ATR)
  • OPK 0.04
  • ECPG 1.08
  • MACD
  • OPK 0.01
  • ECPG -0.22
  • Stochastic Oscillator
  • OPK 70.83
  • ECPG 43.07

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About ECPG Encore Capital Group Inc

Encore Capital Group Inc is an international specialty finance company. It provides debt recovery solutions for consumers and property owners across a broad range of financial assets. The company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as the consumers repay their obligations and work toward financial recovery. Encore has only a reportable segment portfolio purchasing and recovery.

Share on Social Networks: